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Two photon spectroscopy and microscopy of the fluorescent 
flavoprotein, iLOV  
Rachael J. Homans,†a,b Raja U. Khan, †a,b Michael B. Andrews,a Annemette E. Kjeldsen,c Louise S. 
Natrajan,a Steven Marsden,d Edward A. McKenzie,b John M. Christiec and Alex R. Jones*a,b,e 
LOV-domains are ubiquitous photosensory proteins that are commonly re-engineered to serve as powerful and versatile 
fluorescent proteins and optogenetic tools. The photoactive, flavin chromophore, however, is excited using short 
wavelengths of light in the blue and UV, which have limited penetration into biological samples and can cause photodamage. 
Here, we have used non-linear spectroscopy and microscopy of the fluorescent protein, iLOV, to reveal that functional 
variants of LOV can be activated to great effect by two non-resonant photons of lower energy, near infrared light, not only 
in solution but also in biological samples. The two photon cross section of iLOV has a significantly blue-shifted S0 → S1 
transition compared with the one photon absorption spectrum, suggesting preferential population of excited vibronic states. 
It is highly likely, therefore, that the two photon absorption wavelength of engineered, LOV-based tools is tuneable. We also 
demonstrate  for the first time two photon imaging using iLOV in human epithelial kidney cells.. Consequently, two photon 
absorption by engineered, flavin-based bio-molecular tools can enable non-invasive activation with high depth resolution 
and the potential for not only improved image clarity but also enhanced spatiotemporal control for optogenetic applications.
Introduction 
LOV (light, oxygen, or voltage) domains are blue light 
photoreceptor proteins that contain a non-covalently bound 
flavin mononucleotide (FMN) as photoactive chromophore 
(Figure 1).1, 2 In wild-type LOV domains, photoexcitation of FMN 
leads to intersystem crossing,3, 4 and from the protonated triplet 
state a covalent adduct is formed between the C4a of FMN and 
a neighbouring cysteine residue.5 These photophysical and 
photochemical events suppress the fluorescence of the FMN, 
and instead channel much of the absorbed light energy towards 
adduct formation and subsequent changes to protein 
structure.6 LOV serves as a ubiquitous photosensory domain the 
light-triggered structural changes of which are known to 
modulate the activity of a remarkably diverse range of effector 
domains.7, 8 The sensor / effector combinations often adopt 
complex, multidomain architectures allowing LOV domains to 
effect a wide variety of functions in response to light. These 
include the ability of plants to enhance the efficiency of 
photosynthesis through the action of LOV-based blue-light 
receptor kinases known as the phototropins.1 In addition, LOV-
containing photoreceptors facilitate circadian regulation in 
fungi e.g.,9 and mediate a wide variety of functions in bacteria2 
ranging from cell adhesion to stress responses. 
Their modularity and functional versatility mean that 
engineered LOV domains have demonstrated significant utility 
as molecular tools for both the control and imaging of biological 
systems. They are one of the most commonly adapted systems 
for optogenetic applications.10 Here, the genes that encode 
engineered photoreceptor proteins are expressed in target cells 
to enable the optical control of a biological function of interest. 
LOV domains have also been engineered as fluorescent proteins 
(FPs) that, after excitation of the FMN with blue light, emit in 
the green.13, 14 For example, mutations to the monomeric LOV2 
 
 
 
 
 
 
 
 
 
 
Figure 1A. Flavin mononucleotide (FMN), with the approximate S0 → S1 and S0 → S2 
transition dipoles for the one photon absorption of the isoalloxazine chromophore 
indicated with black and red dashed lines, respectively.11 Grey – carbon; blue – nitrogen; 
red – oxygen; pink – phosphorous. B. X-ray crystal structure of iLOV (PDB: 4EES),12 with 
bound FMN (blue). iLOV is an engineered, fluorescent variant of the monomeric LOV2 
domain from Arabidopsis thaliana phototropin 2; the mutated residues (green) are 
labelled. Although not mutated, L472 (yellow) becomes re-orientated in iLOV, which is 
thought to contribute to its improved fluorescence quantum yield.12 
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domain from Arabidopsis thaliana phototropin 2 (Figure 1B) – 
including the adduct-forming cysteine to alanine – have 
produced a FP designated iLOV (“improved LOV”).15 Unlike 
traditional green fluorescent protein (GFP), the green-emitting 
iLOV and similar LOV-based FPs derived from plants12, 16 and 
microorganisms17-21 do not require an aerobic environment for 
fluorescence, are significantly less sensitive to pH and some 
have even been reported to recover after photobleaching.e.g., 15 
Their relatively small size (iLOV ~12 kDa) and monomeric 
structure mean that plant-based LOV FPs are superior 
fluorescent reporters to GFP (~27 kDa) in contexts where the 
size of the biomolecular assembly influences function; e.g., 
plant15 and animal22 RNA viral infection and movement. Finally, 
the rapid onset of fluorescence after expression of LOV-based 
FPs (within a few minutes) compared to GFP (tens of minutes)18 
means they have greater utility as real time in vivo reporters.23  
Despite the potential versatility of LOV-based biomolecular 
tools, flavin-based photoreceptors are activated using short-
wavelength (UV-blue) light.24 This represents a significant 
limitation; such high energy photons can interact strongly with 
biological samples, which severely limits tissue penetration and 
can cause collateral photodamage. Moreover, blue light 
photoreceptors are widespread in nature,24 and therefore the 
use of unfocussed blue light to activate an optogentic tool or FP 
runs the risk of also activating endogenous photoreceptors and 
therefore stimulating off-target responses. The S0 → S1 and S0 
→ S2 electronic transitions of the isoalloxaizine chromophore of 
FMN (Figure 1A), however, are also known to be possible using 
two non-resonant photons of near infrared (NIR) light.25-27 
Indeed, two photon (2P) excitation has been demonstrated for 
the LOV-derived protein, miniSOG, which generates reactive 
oxygen species in response to light.27 NIR overcomes many of 
the problems associated with shorter wavelength light, and 2P 
microscopy is now a common tool for non-invasive bioimaging 
using fluorescent labels28 and label free second harmonic 
generation,29 especially when relatively deep tissue penetration 
is desired. Because 2P excitation requires significant flux 
densities, it often only occurs at the sub-femtolitre focal point 
of a laser beam passed through a high numerical aperture (NA) 
objective lens.30 It therefore enables superior three-
dimensional (3D) spatial resolution for both imaging30 and 
optogenetic activation.31 
Results and Discussion 
We have therefore investigated whether the FMN bound to a 
LOV domain (iLOV, Figure 1B) is amenable to 2P excitation in 
vitro and to 2P imaging in human epithelial kidney (HEK) cells, 
using wavelengths in the NIR. The one photon (1P) absorption 
and emission spectra of FMN bound to iLOV are shown in Figure 
2A. The S0 → S1 transition peaks in the blue (λmax ~ 448 nm) and 
shows the distinctive vibronic structure32 often observed for 
flavins in a protein environment. The emission peak for iLOV is 
blue-shifted by around 35 nm compared to that of free FMN 
(λmax ~ 496 nm), and again vibrational structure is evident; both 
features are typical for LOV-based FPs.e.g.,33 We determined the 
fluorescence quantum yield, ΦF, following 1P excitation of iLOV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2A. Absorption (dashed) and emission (solid) spectra of FMN (blue) and iLOV 
(orange). B. Absorption spectra of iLOV (solid) and the same concentration of FMN 
(dashed) liberated from the protein, revealing an enhanced molar extinction coefficient 
for FMN bound to iLOV around the S0 → S1 transition. C. Fluorescence lifetime data 
(solid) and single exponential fits (dashed) for FMN (blue) and iLOV (orange) after 
photoexcitation at 474 nm. IRF (grey): instrument response function. 
to be ~ 0.30 (Figure S1, Supporting Information). This is lower 
than initially reported for iLOV (ΦF ~ 0.44),15 which was 
calculated based on the assumption that the molar extinction 
coefficients, ε, for FMN and iLOV are the same, and is in line 
with more recent estimates (0.3418 and 0.3334). If FMN is 
released from iLOV, however, it is clear that, like with many 
other LOV-based FPs,33 the ε of FMN around the S0 → S1 
transition is significantly enhanced in iLOV (Figure 2B).34 Whilst 
the ε at ~ 450 nm of FMN in aqueous solution is 12.2 mM−1 
cm−1,33 based on the spectra in Figure 2A this increases 
substantially to ~ 17.6 mM−1 cm−1 when bound to iLOV. The 
fluorescence lifetime, τ, of iLOV (Figure 2C, τ  = 5.27 ± 0.01 ns) 
is longer than that of free FMN (τ = 4.38 ± 0.30 ns). Such 
extended lifetimes are also significantly longer than those of 
GFP derivatives, most of which are < 4 ns.35 It has therefore 
been proposed33 that many LOV-based FPs are more suitable 
than GFPs for Förster resonance energy transfer (FRET) 
imaging36 that is combined with fluorescence lifetime imaging 
microscopy (i.e., FRET-FLIM).37 
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 To initially investigate the potential for non-linear activation 
of LOV-based optical tools, 2P fluorescence spectroscopy38, 39 
was conducted with iLOV. Femtosecond pulses from a Mai Tai 
oscillator were focussed onto the sample using a 40×, 0.6 NA 
microscope objective with an extra-long working distance 
(ELWD), and the fluorescence intensity was measured as a 
function of laser power and excitation wavelength (see 
Experimental Section). Figure 3A shows example fluorescence 
data as a function of laser power after the excitation of iLOV at 
860 nm, and Figure 3B illustrates the non-linear dependence of 
the integrated emission intensity on laser power. Equivalent 
data for FMN in aqueous solution can be found in the 
Supporting Information (Figures S2A&B). The plot in Figure 3C 
of log10(integrated intensity) vs. log10(laser power) confirms 
that the S0 → S1 transition preceding the measured 
fluorescence from iLOV is owing to 2P excitation by the 860 nm 
NIR light, with a gradient of ~ 1.96. Although this gradient for 
iLOV and for free FMN (Figure S2C) are almost exactly equal to 
2, there is a significant sub-quadratic dependence following 2P 
excitation of the S0 → S2 transitions (e.g., 730 nm, Figure S3A, 
Supporting Information). Such a dependence can be attributed 
to a number of factors, but is most likely owing to stimulated 
emission by the focussed beam at higher laser powers40 
(otherwise known as ‘light quenching’).41 Whilst the direction of 
spontaneous emission is random, photons from stimulated 
emission are always directed along the incident laser path and 
therefore 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The 2P fluorescence spectrum (A) and integrated emission intensity (B) of iLOV 
as a function of excitation laser (860 nm) power. The dashed line in B helps to illustrate 
the non-linear dependence of emission intensity on laser power. C. log10(integrated 
emission intensity) as a function of log10(laser power), with corresponding linear fit of 
gradient ~ 1.96. D. 2P absorption cross section (σTPA) spectrum of FMN in aqueous 
solution (blue) and bound to iLOV (orange). E. 1P (orange line) and 2P (purple circles, 
orange line) absorption spectra of iLOV illustrating the ~ 40 nm blue shift of the 2P S0 → 
S1 transition peak relative to the 1P peak. 
never reach the detector, hence a sub-quadratic dependence. 
This effect of stimulated emission was overcome by conducting 
the laser power dependence over a range below ~ 10 mW 
(Figure S3B, Supporting Information). 
Laser power-dependencies were measured for iLOV and 
FMN as a function of 2P excitation wavelength (730 – 970 nm). 
The 2P absorption cross section (σTPA) spectra (Figure 3D) were 
then calculated42 with reference to concurrent and equivalent 
measurements with a fluorescent standard that has a known 
and appropriate σTPA spectrum (fluorescein,43 Figure S4, 
Supporting Information). Refer to the Experimental Section for 
full details. Where there is overlap, the σTPA spectrum of FMN in 
solution is almost identical to that published recently for the 
wavelength range 630 – 900 nm.27 The σTPA spectrum of FMN 
bound to iLOV is qualitatively very similar; both spectra have 
peaks at around 750 and 860 nm, with the short wavelength 
signal having a significantly higher intensity. The relative peak 
intensities in the σTPA spectrum of iLOV are the opposite of 
those observed for the 1P absorption spectrum (Figure 2A), 
which, for a similar LOV-based protein, has been attributed to a 
larger contribution from the dipolar term to the 2P transition 
matrix element.27  
Whereas the 750 nm peak in the 2P spectrum appears to be 
at roughly twice the wavelength of the equivalent transition in 
the 1P spectrum, the 860 nm peak is blue-shifted by at least 40 
nm (Figure 3E). This is perhaps surprising for the isoalloxazine 
chromophore in FMN (Figure 1A), which does not have an 
inversion centre and is thus expected to have a 2P spectrum 
that corresponds to the 1P spectrum but at twice the 
wavelength.38 The S0 → S1 transition peak might therefore be 
expected at around 900 nm (Figure 3E). A similar blue-shift in 
the 2P spectrum of the GFP variant, enhanced GFP, was 
proposed to be owing to the population of a ‘hidden’ excited 
state with a significantly higher transition probability for 2P 
than for 1P absorption.44 An alternative hypothesis was offered 
to explain the blue-shifted 2P spectra of orange and red FPs, 
where it was argued that the signal intensity compared to the 
1P spectrum in each case is redistributed towards a vibronic 
peak at shorter wavelengths.45 This interpretation is supported 
by computational simulations of 2P and 1P spectra of GFP,46 
which suggest non-Condon effects that result in preferential 
population of excited vibrational levels of the S1 state owing to 
a change in the transition dipole moment from 1P to 2P 
absorption. Indeed, the 860 nm peak in the iLOV 2P spectrum 
does coincide with the vibrational shoulder of the S0 → S1 
transition in the 1P spectrum (i.e., at ~ 430 nm) and there 
appears to be a shoulder at around 900 nm in the 2P spectrum 
(Figure 3E). These observations are certainly consistent with a 
redistribution of peak intensities between vibronic states, but 
will need to be corroborated with computational studies into 
the 2P absorption properties of FMN similar to those conducted 
for miniSOG.27 Because FMN and iLOV both have 2P spectral 
peaks at around 860 nm (Figure 3D) the physical origin of this 
blue-shift is not owing to binding of FMN to the protein per se 
and must therefore be an intrinsic property of the chromophore 
electronic structure. That said, different extents of blue-shift 
have been reported for the same chromophore in different red 
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FPs,47 and the 2P cross section of a FP chromophore can also 
vary substantially in different electrostatic environments.48, 49 It 
is therefore likely that the 2P absorption properties of FMN can 
also be tuned by the protein environment to some extent and 
that therefore LOV-based FPs and optogenetic tools can be 
tailored for different 2P activation wavelengths.  
Figure 4 compares 1P and 2P fluorescence microscopy 
images of HEK cells expressing iLOV that were acquired using a 
Leica SP8 Upright Multi-Photon Microscope and a 40×, 1.10 NA 
water-immersion objective lens. Refer to the Experimental 
Section for full details.  Improved image clarity is apparent after 
2P excitation using both 860 nm (Figure 4B) and 900 nm (Figure 
4D) when compared to the equivalent 1P (488 nm, Figures 4A 
and 4C, respectively) image of the same cell or cells. This is true 
whether the 2P image was acquired first (as in Figures 4A&B) or 
the 1P image was acquired first (as in Figures 4C&D), and is 
therefore not an artefact of the bleaching of iLOV fluorescence 
following the acquisition of the 2P image. To probe this 
observation further, a comparison was made of the 
fluorescence intensity profiles across a line of pixels on 
equivalent 1P and 2P images (Figure S5). Any loss of clarity in 
the 1P image is likely to be a result of excess out-of-focus light 
(see discussion below), which would broaden the features on 
the intensity profile. Consistent with this, the profile from the 
2P image does contain slightly sharper, narrower features than 
that from the 1P image. It is also likely, however, that a 
significant contributing factor to any apparent gain in clarity will 
be that the 2P images are marginally brighter (Figure S5B) owing 
to the necessarily higher laser power used in the 2P 
experiments. 
Aside from the potential for a marginal gain in image clarity, the 
benefits of 2P microscopyare at least twofold. First, 2P 
microscopy using iLOV will provide images with high depth 
resolution. If there is less out-of-focus light polluting the 2P 
image it is almost certainly owing to the fact iLOV is only excited 
by 2P in a small very volume at the focal depth of the 
microscope objective.30 1P excitation, by contrast, occurs 
throughout the sample depth and thus emission from parts of 
the sample above and below the chosen focal plane can also be 
detected, thus muddying the image contrast and limiting depth 
resolution. Second, such fine depth resolution suggests that 2P 
activation of LOV-based optogenetic tools will enable high-
precision, 4D spatiotemporal control. Optogenetics using 1P 
activation and pulsed light sources has proven such a powerful 
tool in areas such as neuroscience51 because it allows targeted 
control in both time and space. Because 2P excitation occurs in 
such a small volume, the spatial accuracy will not only improve 
in the X-Y focal plane, but also in the Z-direction (i.e., 3D spatial 
control). Indeed, 2P activation of channelrhodopsin variants has 
previously been exploited to control the activity of neurons in 
culture, slices and in vivo at the level of single cells.31 
Furthermore, the use of femtosecond lasers – which provide the 
necessary photon flux for 2P excitation – in combination with 
new camera technology that enables frame rates of up to 100 
gigaframes per second, has the potential to push the accuracy 
in the temporal dimension into the ultrafast regime.52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Comparison of: the 1P (A, 488 nm) and 2P (B, 860 nm) images of a single HEK293 
cell expressing iLOV; the 1P (C, 488 nm) and 2P (D, 900 nm) images of a group of HEK 
cells expressing iLOV. A gain in image clarity from 1P to 2P excitation of iLOV is apparent 
in each case. Such a gain is not observed when comparing 1P and 2P excitation of the S0 
→ S2 transition (Figure S6). 
Conclusions 
In summary, we have reported the first detailed investigation of 
the 2P activation of an engineered LOV variant in both solution 
and in human cells. In doing so, we show that the extinction 
coefficient for the S0 → S1 transition peak (~450 nm) of the iLOV 
1P absorption spectrum is significantly enhanced (~17.6 mM−1 
cm−1) when compared to FMN free in aqueous solution (~12.2  
mM−1 cm−1). We have therefore been able to calculate a more 
accurate fluorescence quantum yield for iLOV (~0.3) than those 
reported previously.15, 18 Both this and the fluorescence lifetime 
(> 5 ns) are enhanced over free FMN, which makes iLOV a 
suitable energy donor in FRET-FLIM experiments.33 The 2P 
absorption spectrum of FMN and iLOV are very similar. The peak 
of each 2P S0 → S1 transition is at ~ 860 nm and is therefore 
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blue-shifted by at least 40 nm from what is expected from the 
1P spectrum (~ 900 nm). This shift is most likely owing to 
preferential population of an excited vibronic state,49 which is 
in principle sensitive to the electrostatic environment of the 
chromophore.47 The 2P activation wavelength of LOV-based 
tools is therefore likely to be tuneable. We reveal for the first 
time that 2P imaging using iLOV  and NIR in HEK cells, with an 
apparent improvement in image clarity compared to the 
corresponding 1P image using an excitation wavelength of 488 
nm. iLOV is only excited by 2P at the small focal volume of the 
laser, which means the image in the X-Y plane is not obscured 
by out-of-focus light from different sample depths and by 
implication that the Z (depth) resolution is high. In combination 
with short laser pulses, the high spatial resolution afforded by 
the 2P activation of LOV-based tools will facilitate enhanced 4D 
(spatiotemporal) resolution for both imaging and optogenetic 
control. 
Experimental 
Expression and purification of recombinant iLOV 
iLOV was expressed and purified from E. coli as described 
previously.12 Excess FMN (riboflavin 5’-monophosphate sodium 
salt, Sigma) was added to purified iLOV, and unbound FMN 
removed by centrifugal filtration before further purification by 
size exclusion (Sephacryl S-200 HR 16/60, GE Healthcare).  
 
UV-visible absorption and emission spectroscopy 
All spectra of FMN and iLOV were acquired in 50 mM Tris-HCl, 
pH8, 50 mM NaCl. All UV-visible absorption spectra were 
acquired in a 1 cm path length quartz cuvette using an Agilent 
Cary 60 UV-Vis Spectrophotometer. All fluorescence 
measurements were carried out using a FLS920 Edinburgh 
Instruments Spectrofluorometer. Fluorescence emission 
spectra were acquired for an excitation wavelength of 450 nm, 
and fluorescence lifetimes after excitation at 474 nm (from an 
Edinburgh Instruments EPL470 picosecond pulsed diode laser) 
and detection at 530 nm using time correlated single photon 
counting (PCS900 plug-in PC card for fast photon counting). 
Lifetimes were obtained by tail fit to the data obtained or by a 
reconvolution fit using a solution of Ludox® as the scatterer, and 
quality of fit judged by minimisation of reduced chi-squared and 
residuals squared. 
 
iLOV extinction coefficient.  
Absorption spectra were measured using a Shimadzu 
MultiSpec-1501 diode array spectrophotometer at room 
temperature. The optical path length was 0.5 cm and protein 
concentrations were determined by the BCA protein assay 
(Thermo Fisher Scientific) using Bovine Serum Albumin as 
standard. Denatured samples were prepared by incubation at 
100 °C for 15 min in 10 % (w/v) SDS. The concentration of 
liberated FMN was calculated from its peak absorption at ~ 450 
nm using an extinction coefficient, ε450 = 12.2 mM-1 cm-1.33 
The ε450 for iLOV was then calculated from that of FMN and the 
ratio of their peak signal intensities. 
 
Fluorescence quantum yield of iLOV 
The fluorescence quantum yield, ϕs, of iLOV (sample) was 
calculated using a comparative method53 where the integrated 
fluorescence intensity of iLOV was related to that of FMN 
(reference, ϕr = 0.25).33 Measurements were made across a 
number of reference and sample concentrations within the 
range 0 – 1.0 absorbance units at the excitation wavelength 
(450 nm). The integrated fluorescence intensity was then plot 
for both sample and reference as a function of peak absorbance 
at each concentration and the ϕs of iLOV was then calculated 
using: 
 
Φ = 	Φ 	
 

	

      (1) 
 
where, ms and mr at the gradient of the linear fits for sample and 
reference. Both the sample and reference were in aqueous 
solution and therefore their respective refractive indices, η, are 
that of water; the term containing η in equation 1 is therefore 
equal to 1. Although ϕs for iLOV has been estimated 
previously,15 the value of ϕs ~ 0.44 was calculated based on the 
assumption that ε450 for FMN and iLOV are the same. Here, we 
corrected this to account for the ε450 that we have estimated for 
iLOV: i.e., ε450 (FMN) = 12.2 mM-1 cm-1 and ε450 (iLOV) = 17.6 mM-
1 cm-1. 
 
Two photon cross sections 
2P fluorescence measurements we made by focussing the 
tuneable output of a Spectra-Physics Mai Tai Ti:Sapphire 
oscillator (100 fs, 80 MHz) onto the sample using an extra long 
working distance (ELWD), 40× air immersion objective (Nikon 
plan fluor ELWD: 2.80-3.60mm, 0.6 NA). The fluorescence was 
detected in epifluorescence mode via a longpass dichroic mirror 
with a cut-on wavelength of 650 nm (Thor Labs, FEL0650). To 
reduce residual and scattered laser light several shortpass filters 
were used, with cut-off wavelengths of 700, 800 and 900 nm 
(Thor Labs, FES0700, FES0800 and FES0900). Fluorescence was 
collected by a compact CCD spectrometer module (Ocean 
Optics QE65000) and processed using SpectraSuite®. The laser 
power was varied using a neutral density filter, and the emission 
spectra were integrated over the region of maximum emission, 
± 2 nm. Two photon cross sections, σ2,s, for FMN and iLOV 
(sample) were calculated42 every 5 nm in the region 730 – 970 
nm with reference to concurrent and equivalent measurements 
with a fluorescent reference that has a known and appropriate 
σ2,r spectrum (fluorescein, Sigma, reference)43 using: 
 
, = ,		,	 ,      (2) 
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where: F2,s and F2,r are the integrated fluorescent intensities at 
each excitation wavelength; Cs (both FMN and iLOV 70 – 80 µM, 
in 50 mM Tris-HCl, pH8, 50 mM NaCl) and Cr (fluorescein ~ 11 
µM, in 100 mM NaOH(aq)) are the species concentrations;  ϕs 
(iLOV = 0.3; FMN = 0.25) and ϕr (fluorescein = 0.95) are the 
fluorescence quantum yields; the sub-script descriptors ‘s’ and 
‘r’ refer to the sample and reference parameters, respectively. 
 
Mammalian cell culture, transfection and expression 
iLOV-N1 plasmid15 and pEGFPN1 empty vector control plasmid 
(Takara) were amplified by transformation into DH5a 
competent E.coli cells (NEB) and growth in LB media with 25 µg 
ml−1 kanamycin (Sigma). High quality DNA was prepared using a 
Maxi prep kit (Qiagen). HEK293 cells (ATCC) were grown in 
DMEM media (Sigma) supplemented with 10% FBS (Sigma), 2 U 
ml−1 Penicillin and 2 mg ml−1 streptomycin (Sigma) and 2mM 
glutamine (ThermoFisher Scientific) at 37 oC in a humidified 5% 
CO2 incubator. Prior to transfection the HEK293 cells were 
trypsinised (ThermoFisher Scientific) and plated on 10 cm2 Nunc 
petri dishes (ThermoFisher Scientific) at 70% confluency.  Media 
were removed and replaced with reduced serum Opti-MEM 
(ThermoFisher Scientific) without antibiotics and plasmid DNAs 
transfected using Lipofectamine (ThermoFisher Scientific) 
according to the manufacturer’s protocol. The ratio of 24 µg of 
plasmid to 60 µl of lipofectamine was found to be optimal. 
Transfected cells were left for 48hrs at 37 oC to allow a high level 
of protein expression. 
 
Fluorescence microscopy 
1P and 2P fluorescence microscopy images of HEK293 cells 
expressing iLOV were collected on a Leica SP8 Upright 
Multiphoton microscope using a 40×, 1.10 NA HC PL Apo water-
immersion objective and 2x zoom. Images were collected using 
hybrid detectors with fixed filters (BP624/40, HyD3-mCherry; 
BP525/50, HyD4-GFP). 2P excitation at 750, 860 and 900 nm 
was achieved using a Mai Tai MP Ti:Sapphire oscillator (Spectra 
Physics) attenuated to 3% of maximum power. For the data in 
Figure 4, this corresponds to laser powers at the sample plane 
of 18.4 mW (860 nm) and 17.5 mW (900 nm). Multichannel 
images were collected sequentially. When acquiring 3D optical 
stacks the multiphoton software was used to determine the 
optimal number of Z sections. Only the maximum intensity 
projections of these 3D stacks are shown in the results. 1P 
excitation (488 nm) was achieved using a diode laser attenuated 
to 10% of maximum power, which corresponds to a laser power 
at the sample plane of 17 µW. 1P images were collected in the 
confocal regime using a pinhole diameter of 1 airy unit. 
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